The DOI matches its Crossref record; 1,258 of the 1,268 references it cites were found in a registry or an index.
Pharmacology and behavioral pharmacology of the mesocortical dopamine system
Abstract
The prefrontal cortex (PFC) has long been known to be involved in the mediation of complex behavioral responses. Considerable research efforts are directed towards refining the knowledge about the function of this brain area and the role it plays in cognitive performance and behavioral output. In the first part, this review provides, from a pharmacological perspective, an overview of anatomical, electrophysiological and neurochemical aspects of the function of the PFC, with an emphasis on the mesocortical dopamine system. Anatomy of the mesocortical system, basic physiological and pharmacological properties of neurotransmission within the PFC, and interactions between dopamine and glutamate as well as other transmitters within the mesocorticolimbic circuit are included. The coverage of these data is largely restricted to what is relevant for the second part of the review which focuses on behavioral studies that have examined the role of the PFC in a variety of phenomena, behaviors and paradigms. These include reward and addiction, locomotor activity and sensitization, learning, cognition, and schizophrenia. Although the focus of this review is on the mesocortical dopamine system, given the intricate interactions of dopamine with other transmitter systems within the PFC and the importance of the PFC as a source of glutamate in subcortical areas, these aspects are also covered in some detail where appropriate. Naturally, a topic as complex as this cannot be covered comprehensively in its entirety. Therefore this review is largely limited to data derived from studies using rats, and it is also specifically restricted to data concerning the medial PFC (mPFC). Since in several fields of research the findings concerning the function or role of the mPFC are relatively inconsistent, the question is addressed whether these inconsistencies might, at least in part, be related to the anatomical and functional heterogeneity of this brain area.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, in frontal cortex, because of low concentrations of the dopamine reuptake molecule DAT, it takes much longer to clear dopamine from synapses (for reviews, see, e.g., [72–74]).”
From Cortical and basal ganglia contributions to habit learning and automaticity (2010) · cites this paper as [72]
Citations
Cites
Plum, F. (1960) · Archives of Neurology · doi:10.1001/archneur.1960.03840090124020 · Cited by 10,388
A neural substrate of prediction and reward
Schultz, W., Dayan, P., & Montague, P. R. (1997) · Science · doi:10.1126/science.275.5306.1593 · Cited by 9,388
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
Handbook of Chemical Neuroanatomy
Stern, C. D. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90021-5 · Cited by 4,160
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Morris, R. G. M., Anderson, E., Lynch, G. S., & Baudry, M. (1986) · Nature · doi:10.1038/319774a0 · Cited by 3,640
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
The somatic marker hypothesis and the possible functions of the prefrontal cortex
Damasio, A. R. (1996) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1996.0125 · Cited by 2,847
Research works printed but not linked: 50
- Arvanitogiannis, 1997, Fos expression following self-stimulation of the medial prefrontal cortex, Soc. Neurosci. Abstr., 23, 2384
- Bauco, 1994, Extracellular nucleus accumbens dopamine and metabolite levels during earned and unearned lateral hypothalamic brain stimulation, Soc. Neurosci. Abstr., 20, 823
- Carr, G.D., Fibiger, H.C., Phillips, A.G., 1989. Conditioned place preference as a measure of drug reward. In: J.M. Liebman, S.J. Cooper (Eds.), The Neuropharmacological Basis of Reward. Clarendon Press, Oxford, pp. 264–319.
- Carter, 1980, Glutamatergic pathways from the medial pre-frontal cortex to the anterior striatum, nucleus accumbens and substantia nigra, Br. J. Pharmacol., 70, 50
- Carter, 1978, Studies on the roles of catecholamines in the frontal cortex, Br. J. Pharmacol., 62, 402P
- Childress, 1996, Brain correlates of cue-induced and opiate craving, Soc. Neurosci. Abstr., 22, 365.5
- Conover, 1992, Coactivation of the lateral hypothalamus and ventral tegmental area yields greater reward summation than coactivation of the lateral hypothalamus and medial pre-frontal cortex, Soc. Neurosci. Abstr., 18, 709
- Di Chiara, 1992, Heterologous monoamine uptake: lack of transmitter specificity of neuron-specific carriers, Neurochem. Int., 20, 231S
- Ditzler, 1991, Efficacy and tolerability of memantine in patients with dementia syndrome, Arzneimittelforschung/Drug Res., 8, 773
- Douglin, 1979, Gradual increases in self-stimulation response rates: effect of electrode loci, Physiol. Behav., 7, 135
- Feenstra, 1993, In vivo dopamine release in the rat prefrontal cortex is increased by stimulation of mediodorsal thalamic nucleus, Soc. Neurosci. Abstr., 19, 1382
- Feenstra, 1995, Local application of a competitive NMDA antagonist in the medial prefrontal cortex increases in vivo DA but not NA release, Br. J. Pharmacol., 114, 328P
- Forno, L.S., 1990. Pathology of Parkinson's disease: the importance of the substantia nigra and Lewy bodies. In: Stern, G. (Ed.), Parkinson's Disease. Chapman and Hall, London, pp. 185–238.
- Fuster, J., 1980. The prefrontal cortex. Raven Press, New York.
- Gabbott, 1996, Local circuit neurons in the medial prefrontal cortex (areas 24a,b,c, 25 and 32) in the monkey: II. Quantitative arial and laminar distributions, J. Comp. Neurol., 364, 609, 10.1002/(SICI)1096-9861(19960122)364:4<609::AID-CNE2>3.0.CO;2-7 · DOI
- Gillham, 1990, GABA neurons in the ventral tegmental area project to the medial prefrontal cortex: a non-dopaminergic mesocortical system, Soc. Neurosci. Abstr., 16, 105
- Grace, 1984, Electrophysiology and morphology of four classes of prefrontal neocortical neurons studied in vitro, Soc. Neurosci. Abstr., 10, 739
- Gresch, 1995, Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat, J. Neurochem., 65, 575, 10.1046/j.1471-4159.1995.65010111.x · DOI
- Hemby, 1990, Neuropharmacological assessment of cocaine-induced conditioned place preference using intra-cranial microinjections, Soc. Neurosci. Abstr., 16, 243.6
- Hoffmann, 1986, Multiple effects of neuronal uptake inhibitors on transmitter release, J. Pharmacol. Exp. Ther., 238, 437
- Koob, G.F., Goeders, N.E., 1989. Neuroanatomical substrates of drug self-administration. In: Liebman, J.M., Cooper, S.J. (Eds.), The neuropharmacological basis of reward. Clarendon Press, Oxford, pp. 214–236.
- Kuczenski, R., Segal, D.S., 1994. Neurochemistry of amphetamine. In: Cho, A., Segal, D.S. (Eds.), Amphetamine and its analogs. Academic Press, San Diego, pp. 81–113.
- Kurata, 1993, Differential effects of tight and loose 2-h restraint stress on extracellular concentrations of dopamine in nucleus accumbens and anteromedial frontal cortex, Jpn. J. Psychiatry Neurol., 47, 57
- Lindvall, O., Björklund, A., 1984. In: Descarries, L., Reader, T.R., Jasper, H.H. (Eds.), General organization of cortical monoamine systems. Liss, New York.
- Lu, 1997, Expression of D1 receptor mRNA in projections from the forebrain to the ventral tegmental area, Synapse, 25, 205, 10.1002/(SICI)1098-2396(199702)25:2<205::AID-SYN11>3.0.CO;2-X · DOI
- Moore, 1996, Interactions between amygdala and prefrontal cortical afferents to the nucleus accumbens and their modulation by dopamine receptor activation, Soc. Neurosci. Abstr., 22, 1088
- Moore, R.Y., Card, J.P., 1984. Noradrenaline-containing neuron systems. In: Björklund, A., Hökfelt, T. (Eds.), Handbook of Chemical Neuroanatomy, vol. 2. Elsevier, Amsterdam, pp. 123–156.
- Muly, 1997, D1 dopamine receptors are present in parvalbumine-positive interneurons in macaque prefrontal cortex, Soc. Neurosci. Abstr., 23, 1772
- Nishijima, 1996, Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis, Synapse, 22, 304, 10.1002/(SICI)1098-2396(199604)22:4<304::AID-SYN2>3.0.CO;2-F · DOI
- Nonneman, 1974, Comparisons of behavioral effects of hippocampal and prefrontal cortex lesions in the rat, J. Comp. Physiol. Psychol., 87, 249, 10.1037/h0036864 · DOI
- Palkovits, M., 1979. Dopamine levels of individual brain regions: biochemical aspects of DA distribution in the central nervous system. Academic Press, London, pp. 343–356.
- Phillips, A.G., Fibiger, H.C., 1989. Neuroanatomical bases of intracranial self-stimulation: untangling the Gordian knot. In: Liebman, J.M., Cooper, S.J. (Eds.), The neuropharmacological basis of reward. Clarendon Press, Oxford, pp. 66–105.
- Pickel, V.M., Sesack, S.M., 1995. Electron microscopy of central dopamine systems. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The fourth generation of progress. Raven Press, New York, pp. 257–268.
- Seamans, 1995, Selective impairment on a delayed radial arm task following local administration of a D1, but not a D2, antagonist into the prefrontal cortex, Soc. Neurosci. Abstr., 21, 1942
- Shibata, 1990, Effect of dopamine agonists on locomotor activity of anteromedial frontal cortex lesioned rats, Jpn. J. Psychiatry Neurol., 44, 789
- Shippenberg, 1993, Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D1 versus D2 dopamine receptors, J. Pharmacol. Exp. Ther., 265, 53
- Simon, 1981, Dopaminergic A10 neurons and the frontal system, J. Physiol., 77, 81
- Smiley, 1996, Serotonergic axons in monkey prefrontal cerebral cortex synapse predominantly on interneurons as demonstrated by serial section electron microscopy, J. Comp. Neurol., 367, 431, 10.1002/(SICI)1096-9861(19960408)367:3<431::AID-CNE8>3.0.CO;2-6 · DOI
- Smith, 1998, Microcircuitry of the direct and indirect pathways of the basal ganglia, Neuroscience, 86, 353
- Stellar, J.R., Rice, M.B., 1989. Pharmacological basis of intracranial self-stimulation reward. In: Liebman, J.M., Cooper, S.J. (Eds.), The neuropharmacological basis of reward. Clarendon Press, Oxford, pp. 14–65.
- Taylor, 1978, Comparison of monoamine uptake by cocaine, methylphenidate and amphetamine, Res. Commun. Pathol. Pharmacol., 21, 67
- Thierry, A.M., Tassin, J.P., Blanc, G., Glowinski, J., 1976b. Topographical and pharmacological study of the mesocortical dopaminergic systems. In: Wauqnier, A., Rolls, E.T. (Eds.), Brain Stimulation Reward. North-Holland, Amsterdam, pp. 290–293.
- Tzschentke, 1997, Electrical stimulation of the medial prefrontal cortex elicits release of dopamine and glutamate in nucleus accumbens and ventral tegmental area in rats: effects of different frequencies and currents, Soc. Neurosci. Abstr., 23, 1753
- Tzschentke, T.M., Schmidt, W.J., 1998b. Functional heterogeneity of the medial prefrontal cortex and its relevance for drug reward. On-line Proceedings of the Fifth Internet World Congress on Biomedical Sciences (INABIS)’ 98 at McMaster University, Canada (available from URL: http://www.mcmaster.ca/inabis98/).
- Uylings, H.B.M., van Eden, C.G., De Bruin, J.P.C., Corner, M.A., Feenstra, M.G.P. (Eds.), 1990. The prefrontal cortex—its structure, function and pathology. Progress in Brain Research, vol. 85. Elsevier, Amsterdam.
- van Eden, 1997, Efferents from the rat medial prefrontal cortex can influence dopaminergic cells in the ventral tegmental area, which project to the nucleus accumbens, Soc. Neurosci. Abstr., 23, 1213
- Weiner, 1990, Disruption of latent inhibition by a low dose of amphetamine is antagonised by haloperidol and apomorphine, J. Psychopharmacol., 4, 255
- White, F.J., Wachtel, S.R., Johansen, P.A., Einhorn, L.C., 1987. Electrophysiological studies of the rat mesoaccumbens dopamine systems: focus on dopamine receptor subtypes, interactions, and the effect of cocaine. In: Chiodo, L.A., Freeman, F.A. (Eds.), Neurophysiology of dopaminergic systems: current status and clinical perspectives. Lakeshore, Detroit, pp. 317–365.
- White, F.J., Hu, X.T., Henry, D.J., Zhang, X.F., 1995a. Neurophysiological alterations in the mesocorticolimbic dopamine system with repeated cocaine administration. In: Hammer Jr, R.P. (Ed.), The Neurobiology of Cocaine: Cellular and Molecular Mechanisms. CRC Press, Boca Raton, FL, pp. 99–119.
- Yang, 1996, Focal dendritic D1 receptor stimulation differentially modulates layers I-II and V-VI glutamate inputs to deep layer prefrontal cortical pyramidal neurons in vitro, Soc. Neurosci. Abstr., 22, 1770
Cited by
Sorted by citations
Items 301–400 of 481
Alaei, H., Radahmadi, M., Ramshini, E., Hosseini, N., & Karimi, S. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.124643 · Cited by 11
Jalloh, K., Roeder, N. M., Hamilton, J., Delis, F., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118708 · Cited by 11
SUN, J., Dong, Y. W., FU, Y., Zhu, Y. Z., Dong, Y. W., & ZHENG, P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.03.022 · Cited by 11
Neurochemical Coding of Adaptive Responses in the Limbic System
Herbert, J., & Schulkin, J. A. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50013-5 · Cited by 11
Is there a role for uridine and pyrimidine nucleosides in the treatment of vascular dementia?
Fornai, F., Busceti, C. L., Ferrucci, M., Lazzeri, G., & Ruggieri, S. A. (2002) · PubMed · Cited by 11
Lessard, A., Grady, E. F., Bunnett, N. W., & Pickel, V. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.058 · Cited by 11
Porcu, P., Lallai, V., Locci, A., Catzeddu, S., Serra, V., Pisu, M. G., Serra, M., Dazzi, L., & Concas, A. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4511-7 · Cited by 10
The endogenous cannabinoid system modulates male sexual behavior expression
Rodríguez–Manzo, G., & Canseco-Alba, A. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1198077 · Cited by 11
Confused about NMDA and Addiction? Targeted Knockouts Provide Answers and New Questions
Carr, D. B., & Kalivas, P. W. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.025 · Cited by 10
Chen, T., Zhang, D., Dragomir, A., Kobayashi, K., Akay, Y. M., & Akay, M. (2011) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/1743-0003-8-58 · Cited by 10
Li, Y.-C., Yang, S.-S., & Gao, W. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.05.002 · Cited by 10
Dopaminergic Epistases in Schizophrenia
Bosun, A., Kalinovic, R., Neda-Stepan, O., Bosun, I., Farcaş, S. S., ENĂTESCU, V. R., & Andreescu, N. I. (2024) · Brain Sciences · doi:10.3390/brainsci14111089 · Cited by 9
Involvement of the Mesocorticolimbic Dopaminergic System in Adaptive Behavior
Ivlieva, N. Y. (2011) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-011-9477-7 · Cited by 9
Homberg, J. R., Wardeh, G., Raasø, H. S., Schoffelmeer, A. N. M., & Vries, T. J. D. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.07.001 · Cited by 9
Ghavipanjeh, G., Pourshanazari, A. A., Alaei, H., Karimi, S., & Nejad, M. A. (2015) · Europe PMC (PubMed Central) · Cited by 9
Motor and cognitive functions of the neostriatum during bilateral blockade of its dopamine receptors
Shapovalova, K. B., & Kamkina, Y. V. (2007) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-008-0010-6 · Cited by 9
The role of serotoninergic system in psychostimulant effects
Taracha, E. (2021) · Postępy Psychiatrii i Neurologii · doi:10.5114/ppn.2021.111939 · Cited by 8
Lissek, S., Vallana, G. S., Schlaffke, L., Lenz, M., Dinse, H. R., & Tegenthoff, M. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00201 · Cited by 8
Dunn, M. J., & Killcross, S. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0714-2 · Cited by 8
A short history of latent inhibition research
Lubow, R. E. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511730184.002 · Cited by 8
Behavioural neurobiology of feather pecking
van Hierden, & Margreet, Y. (2003) · Cited by 8
Guzman, D. D., Moscarello, J. M., & Ettenberg, A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.01.003 · Cited by 8
Rogowski, A. (2003) · Alcohol and Alcoholism · doi:10.1093/alcalc/agg081 · Cited by 8
Novel antipsychotic agents: recent advances in the drug treatment of schizophrenia
Butini, S., Campiani, G., Angelis, M. D., Fattorusso, C., Nacci, V., & Fiorini, I. (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.4.425 · Cited by 8
Siemiątkowski, M., Maciejak, P., Wisłowska, A., Zienowicz, M., Sienkiewicz‐Jarosz, H., Szyndler, J., Członkowska, A. I., Bidziński, A., Gryczyńska, A., & Płaźnik, A. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.06.026 · Cited by 8
Addiction and Glutamate-Dependent Plasticity
Wolf, M. E. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-306-4_8 · Cited by 8
The Neurobiology of Schizophrenia
Bobo, W. V., Rapoport, J. L., Abi‐Dargham, A., Fatemi, S. H., & Meltzer, H. Y. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch19 · Cited by 8
Duan, Y., Shen, F., Gu, T., & Sui, N. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.00816 · Cited by 6
Alaee, E., Pachenari, N., Khani, F., Semnanian, S., Shojaei, A., & Azizi, H. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110803 · Cited by 8
Role of GABA Deficit in Sensitivity to the Psychotomimetic Effects of Amphetamine
Ahn, K., Sewell, A. R., Elander, J., Pittman, B., Ranganathan, M., Gunduz-Bruce, H., Krystal, J., & D'Souza, D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.132 · Cited by 8
Brain kinin B1 receptor contributes to the onset of stereotypic nocifensive behavior in rat
Gariépy, H. D. B., Talbot, S., Sénécal, J., & Couture, R. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.032 · Cited by 7
Evaluation of the CART peptide expression in morphine sensitization in male rats
Bakhtazad, A., Vousooghi, N., Garmabi, B., & Zarrindast, M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.040 · Cited by 7
Rodrı́guez–Manzo, G., González-Morales, E., & Garduño‐Gutierrez, R. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.701290 · Cited by 7
Bergum, N., Berezin, C.-T., King, C. M., & Vı́gh, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415870 · Cited by 7
The Abuse Liability of Dextromethorphan Among Adolescents: A Review
Bobo, W. V., Miller, S. C., & Martin, B. D. (2005) · Journal of Child & Adolescent Substance Abuse · doi:10.1300/j029v14n04_04 · Cited by 7
Esumi, S., Kawasaki, Y., Nakamoto, A., Sagara, H., Gomita, Y., Kitamura, Y., & Sendo, T. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.079 · Cited by 8
Chen, H.-T., & Chen, J. (2015) · Learning & Memory · doi:10.1101/lm.037721.114 · Cited by 8
Memory-specific encoding activities of the ventral tegmental area dopamine and GABA neurons
Glykos, V., & Fujisawa, S. (2023) · eLife · doi:10.7554/elife.89743 · Cited by 12
Ramos‐Ortolaza, D. L., Negrón, A., Cruz, D., Falcón, E., Iturbe, M. C., Cajigas, M. H., & Maldonado-Vlaar, C. S. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.006 · Cited by 6
Adolescent neurostimulation of dopamine circuit reverses genetic deficits in frontal cortex function
Mastwal, S. S., Li, X., Stowell, R. D., Manion, M. T. C., Zhang, W., Kim, N., Yoon, K., Song, H., Ming, G., & Wang, K. H. (2023) · eLife · doi:10.7554/elife.87414 · Cited by 14
Illenberger, J. M., Flores‐Ramirez, F. J., Matzeu, A., Lütjens, R., & Martin‐Fardon, R. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109666 · Cited by 6
Chen, T. Y., Zhang, D., Dragomir, A., Akay, Y. M., & Akay, M. (2011) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-011-0759-6 · Cited by 6
Mescaline-induced behavioral alterations are mediated by 5-HT2A and 5-HT2C receptors in rats
Olejníková, L., Fujáková-Lipski, M., Šíchová, K., Danda, H., Syrová, K., Horáček, J., & Páleníček, T. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173903 · Cited by 5
DFT, molecular docking and receptor inhibition analysis of neuromodulatory molecule- dopamine
Zaidi, N., Mir, M. A., Chang, S. K., Abdelli, N., & Andrews, K. (2025) · Current Pharmaceutical Analysis · doi:10.1016/j.cpan.2025.04.003 · Cited by 5
Cid-Jofré, V., Moreno, M., Sotomayor‐Zárate, R., Cruz, G., & Renard, G. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126602 · Cited by 5
Schizophrenia: The Ambiguous Mechanism behind the Disorder
Al-Nema, M. Y., & Gaurav, A. (2022) · Jordan Journal of Pharmaceutical Sciences · doi:10.35516/jjps.v15i2.323 · Cited by 5
Olianas, M. C., Dedoni, S., & Onali, P. (2012) · Neurosignals · doi:10.1159/000335208 · Cited by 5
Ménard, S., Gelez, H., Jacubovich, M., Coria‐Ávila, G. A., & Pfaus, J. G. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104858 · Cited by 5
The serotonin2B receptor and neurochemical regulation in the brain
Spampinato, U., Cathala, A., & Devroye, C. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00007-4 · Cited by 5
Zhu, Y.-P., Zai-hao, L., Zheng, M., & Binsack, R. (2006) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2006.b0998 · Cited by 5
Alaei, H., Mehdipour, S., & Pilehvarian, A. A. (2015) · Advanced Biomedical Research · doi:10.4103/2277-9175.170679 · Cited by 5
Effects on behavioral sensitization and intravenous cocaine self-administration "binges"
Covington, H. E., & Miczek, K. A. (2001) · Cited by 5
Liao, R., & Lin, H.-L. (2008) · PubMed · Cited by 4
Cengiz, M., Bayoğlu, B., Cezayirli, E., Aslıyüksek, H., & Kocabaşoğlu, N. (2019) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_194_18 · Cited by 4
I., R. M. M. (2005) · Frontiers in bioscience · doi:10.2741/1723 · Cited by 4
Technique for eliminating nonessential components in the refinement of a model of dopamine neurons
Oprisan, S. A., & Canavier, C. C. (2006) · Neurocomputing · doi:10.1016/j.neucom.2005.12.039 · Cited by 4
Ventromedial prefrontal cortex is involved in preference and hedonic evaluation of tastes
Berta, B., Kertes, E., Péczely, L., Ollmann, T., László, K., Gálosi, R., Kállai, V., Petykó, Z., Zagorácz, O., Kovács, A., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.03.051 · Cited by 4
Hu, J. H., Leitzell, K., Wang, D., & Quick, M. W. (2006) · Wiley eBooks · doi:10.1002/9780470101001.hcn016 · Cited by 4
Synaptic Changes in Mice Lacking Alpha- and Gamma-Synucleins
Krayushkina, A. M., Morozova, O., Khizeva, A., Ivanova, T. A., Ninkina, N. N., & Chaprov, K. (2025) · Biomedicines · doi:10.3390/biomedicines13122866 · Cited by 3
Prefrontal Cortical Dopamine Transmission
Sesack, S. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418675-0.00015-8 · Cited by 5
Selective antagonists of calcium-permeable GluA1 AMPA-receptors as potential antiaddictive agents
Potapkin, A. M., Гмиро, В. Е., & Shabanov, P. D. (2023) · Психофармакология и биологическая наркология · doi:10.17816/phbn267069 · Cited by 4
Tetteh-Quarshie, S., Morrison, K. M., Olszewski, N. A., Young, L. E., Mensah, E. N., Sword, M. K., & Henderson, B. J. (2025) · Physiology and Behavior · doi:10.1016/j.physbeh.2025.114823 · Cited by 2
Relationship of Dopamine of the Nucleus Accumbens with Intra-infralimbic Apomorphine Microinjection.
Alimoradian, A., Sajedianfard, J., Zarandi, F. B. B., Panjehshahin, M. R., & Owji, A. A. (2013) · Europe PMC (PubMed Central) · Cited by 3
Neurobiological Mechanisms of Addictive Behavior
Ivlieva, N. Y. (2012) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-012-9619-6 · Cited by 3
Xue, B., Mao, L., Jin, D.-Z., & Wang, J. Q. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.022 · Cited by 3
Benzisoxazole derivatives as Atypical Antipsychotic drugs: A Review
Chandra, S., & Sharada, A. C. (2014) · Cited by 3
McDougall, S. A., Montejano, N. R., Park, G. I., & Robinson, J. A. M. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-02011-z · Cited by 3
Майоров, В. И., & Frolov, A. G. (2005) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-005-0107-0 · Cited by 3
Acute D2/D3 Dopaminergic Agonism but Chronic D2/D3 Antagonism Prevents NMDA Antagonist Neurotoxicity
Farber, N. B., Nemmers, B., & Noguchi, K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.019 · Cited by 3
Klejbor, I., Ludkiewicz, B., Wojcik, S. P., & Turlejski, K. (2013) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2013-1957 · Cited by 3
Evidence from brain imaging studies for dopaminergic alterations in schizophrenia
Abi‐Dargham, A. (2003) · CRC Press eBooks · doi:10.3109/9780203427347-3 · Cited by 3
2.2 Functional Implications of Dopamine D2 Receptor Localization in Relation to Glutamate Neurons
Sesack, S. R. (2009) · doi:10.1093/acprof:oso/9780195373035.003.0003 · Cited by 3
Eiler, W. J. A., Gleason, S. D., Smith, J. L., & Witkin, J. M. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.06.005 · Cited by 3
Crawford, C. A., Teran, A., Ramirez, G. I., Katz, C. G., Mohd‐Yusof, A., Eaton, S. E., Real, V., & McDougall, S. A. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24491 · Cited by 3
Gene polymorphisms associated with temperament in Merino sheep
Qiu, X. (2015) · Cited by 2
Asefi, M. B., Heidari, A., Hajikarim‐Hamedani, A., Mousavi, Z., Ashabi, G., Sadat‐Shirazi, M., & Zarrindast, M. (2024) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2024.107367 · Cited by 2
Kryst, J., Chocyk, A., Solarz, A., & Majcher‐Maślanka, I. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00712-x · Cited by 2
Varenicline and evaluated outcomes in smoking cessation programmes
Santus, P., Bassi, L., Airoldi, A., Giovannelli, F., & Radovanovic, D. (2015) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2013.105 · Cited by 2
Lopes, D. B., do Nascimento, G. N. L., de Carvalho, A. A. V., Neto, A. C. S., de Lima, N. E., & Aversi‐Ferreira, T. A. (2009) · International Journal of Morphology · doi:10.4067/s0717-95022009000300009 · Cited by 2
Шубенина, Е. В., Кудрин, В. С., Михайлович, К. П., Наркевич, В. Б., Кузнецова, Е. А., Гудашева, Т. А., & Ostrovskaya, R. U. (2012) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-012-1801-x · Cited by 2
Stable and Unstable Activation of the Prefrontal Cortex with Dopaminergic Modulation
Tanaka, S. (2007) · Springer eBooks · doi:10.1007/978-0-387-72256-6_16 · Cited by 2
THE EFFECT OF VITAMIN C ON EXPRESSION OF MORPHINE-INDUCED CONDITIONED PLACE PREFERENCE IN MALE MICE
Abbasi-Maleki, S., Najafi, G., & Eftekhari, S. (2012) · Cited by 2
Schwarz, A. P., Трофимов, А. Н., Zubareva, O. E., Lioudyno, V. I., Kosheverova, V., Ischenko, A. M., & Клименко, В. М. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.06.052 · Cited by 2
Schwarz, A. P., Rotov, A. Y., Chuprina, O. I., Krytskaya, D. U., Трофимов, А. Н., Kosheverova, V., Ischenko, A. M., & Zubareva, O. E. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.08.008 · Cited by 2
Papadeas, S. T. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/xraa-7j71 · Cited by 2
Functional neuroanatomy of cognition in Parkinson's disease
Mirpour, K., Wolfe, C. B., Florence, T. J., & Pouratian, N. (2022) · Progress in brain research · doi:10.1016/bs.pbr.2022.01.007 · Cited by 2
Cortical Dopamine in Schizophrenia
Abi‐Dargham, A. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_1 · Cited by 2
Conditional and non-conditional reward- related responses to alcohol - nicotinic mechanisms
Löf, E. (2006) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 2
Wotjak, C. T. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_1 · Cited by 2
From the Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Wadman, C. (2007) · Cited by 2
Elsworth, J. D., & Roth, R. H. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.00683-5 · Cited by 2
Role of Prefrontal Cortex Dopamine and Noradrenaline Circuitry in Addiction
Carboni, E., Cadeddu, R., & Rosa, A. (2012) · InTech eBooks · doi:10.5772/51221 · Cited by 1
Haraldsson, M. H. (2010) · Cited by 1
Cocaine Addiction: Changes in Excitatory and Inhibitory Neurotransmission
Antonio, E., & Alfredo, E. (2012) · InTech eBooks · doi:10.5772/34410 · Cited by 1
Alimoradian, A., Zarandi, F. B. B., Sajedianfard, J., & Panjehshahin, M. R. (2009) · Iranian journal of basic medical sciences. · doi:10.22038/ijbms.2009.5183 · Cited by 1
Chen, T., Dragomir, A., Zhang, D., Akay, Y. M., & Akay, M. (2010) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2010.5626088 · Cited by 1
GABAergic Agents for the Treatment of Nicotine Dependence
Sofuoglu, M., & Lappalainen, J. (2006) · CRC Press eBooks · doi:10.1201/9781420005431.ch12 · Cited by 1
Mehdipour, S., Alaei, H., Reisi, P., & Marghmaleki, V. S. (2016) · Advanced Biomedical Research · doi:10.4103/2277-9175.192730 · Cited by 1
Cyproheptadine Regulates Pyramidal Neuron Excitability in Mouse Medial Prefrontal Cortex
He, Y., Wang, K., Zhao, Q., & Mei, Y. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0225-7 · Cited by 1
Neuroimaging Biomarkers in Schizophrenia
Tost, H., & Meyer‐Lindenberg, A. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_11 · Cited by 1
Metadata
- Authors
- Tzschentke, T. M.
- Affiliations
- Grünenthal Group (Germany) (DE)
- Corresponding author
- Tzschentke, T.M.
- ORCID
- Tzschentke, T.M.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2001-02
- Volume
- 63
- Issue
- 3
- Pages
- 241-320
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W2111304405
- Semantic Scholar
- 314205aef63746557803f0214ed764321bbe28dc
- Cited by
- 481
- References
- 1,268
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 9 · 2023: 19 · 2022: 7 · 2021: 6 · 2020: 8 · 2019: 13 · 2018: 6 · 2017: 17 · 2016: 14 · 2015: 24 · 2014: 21 · 2013: 11 · 2012: 24
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- mesocortical dopamine system, prefrontal cortex, medial prefrontal cortex, glutamate, dopamine-glutamate interaction, mesocorticolimbic circuit, reward, addiction, locomotor activity, sensitization, learning, cognition, schizophrenia
- MeSH terms
- Animals, Behavior, Animal, Dopamine, Humans, Synaptic Transmission, Neurons, Prefrontal Cortex, Ventral Tegmental Area
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review